244 related articles for article (PubMed ID: 22111980)
1. Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population.
Vasilopoulos Y; Manolika M; Zafiriou E; Sarafidou T; Bagiatis V; Krüger-Krasagaki S; Tosca A; Patsatsi A; Sotiriadis D; Mamuris Z; Roussaki-Schulze A
Mol Diagn Ther; 2012 Feb; 16(1):29-34. PubMed ID: 22111980
[TBL] [Abstract][Full Text] [Related]
2. Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
Vasilopoulos Y; Bagiatis V; Stamatopoulou D; Zisopoulos D; Alexiou I; Sarafidou T; Settas L; Sakkas L; Mamouris Z
Clin Exp Rheumatol; 2011; 29(4):701-4. PubMed ID: 21813066
[TBL] [Abstract][Full Text] [Related]
3. Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
Xu F; Zhou G; Han S; Yuan W; Chen S; Fu Z; Li D; Zhang H; Li D; Pang D
PLoS One; 2014; 9(7):e101138. PubMed ID: 25010932
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease.
Steenholdt C; Enevold C; Ainsworth MA; Brynskov J; Thomsen OØ; Bendtzen K
Aliment Pharmacol Ther; 2012 Oct; 36(7):650-9. PubMed ID: 22860894
[TBL] [Abstract][Full Text] [Related]
5. Role of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis.
Xing-Rong W; Sheng-Qian X; Wen L; Shan Q; Fa-Ming P; Jian-Hua X
Medicine (Baltimore); 2018 Aug; 97(31):e11677. PubMed ID: 30075559
[TBL] [Abstract][Full Text] [Related]
6. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
[TBL] [Abstract][Full Text] [Related]
7. The role of Fcγ receptor polymorphisms in the response to anti–tumor necrosis factor therapy in psoriasis A pharmacogenetic study.
Julià M; Guilabert A; Lozano F; Suarez-Casasús B; Moreno N; Carrascosa JM; Ferrándiz C; Pedrosa E; Alsina-Gibert M; Mascaró JM
JAMA Dermatol; 2013 Sep; 149(9):1033-9. PubMed ID: 24048425
[TBL] [Abstract][Full Text] [Related]
8. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients.
González-Lara L; Batalla A; Coto E; Gómez J; Eiris N; Santos-Juanes J; Queiro R; Coto-Segura P
Arch Dermatol Res; 2015 Jul; 307(5):405-12. PubMed ID: 25537528
[TBL] [Abstract][Full Text] [Related]
9. Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab.
Medrano LM; Taxonera C; Márquez A; Barreiro-de Acosta M; Gómez-García M; González-Artacho C; Pérez-Calle JL; Bermejo F; Lopez-Sanromán A; Martín Arranz MD; Gisbert JP; Mendoza JL; Martín J; Urcelay E; Núñez C
Hum Immunol; 2014 Jan; 75(1):71-5. PubMed ID: 24121042
[TBL] [Abstract][Full Text] [Related]
10. A Pharmacogenetic Study of Psoriasis Risk Variants in a Greek Population and Prediction of Responses to Anti-TNF-α and Anti-IL-12/23 Agents.
Masouri S; Stefanaki I; Ntritsos G; Kypreou KP; Drakaki E; Evangelou E; Nicolaidou E; Stratigos AJ; Antoniou C
Mol Diagn Ther; 2016 Jun; 20(3):221-5. PubMed ID: 27043841
[TBL] [Abstract][Full Text] [Related]
11. The relationship between tumour necrosis factor (TNF)-α promoter and IL12B/IL-23R genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study.
Gallo E; Cabaleiro T; Román M; Solano-López G; Abad-Santos F; García-Díez A; Daudén E
Br J Dermatol; 2013 Oct; 169(4):819-29. PubMed ID: 23662788
[TBL] [Abstract][Full Text] [Related]
12. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis.
Chatzikyriakidou A; Georgiou I; Voulgari PV; Drosos AA
Clin Exp Rheumatol; 2009; 27(4):645-8. PubMed ID: 19772798
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
[TBL] [Abstract][Full Text] [Related]
14. TNF receptor I polymorphism is associated with persistent palindromic rheumatism.
Lu LY; Keng HM; Chu JJ; Lin XT; Hsu CM; Sung PK
Scand J Rheumatol; 2007; 36(4):278-84. PubMed ID: 17763205
[TBL] [Abstract][Full Text] [Related]
15. Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis.
Ryan C; Kelleher J; Fagan MF; Rogers S; Collins P; Barker JN; Allen M; Hagan R; Renfro L; Kirby B
Clin Exp Dermatol; 2014 Jun; 39(4):519-24. PubMed ID: 24758522
[TBL] [Abstract][Full Text] [Related]
16. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs.
Ovejero-Benito MC; Muñoz-Aceituno E; Sabador D; Almoguera B; Prieto-Pérez R; Hakonarson H; Coto-Segura P; Carretero G; Reolid A; Llamas-Velasco M; Abad-Santos F; Daudén E
Exp Dermatol; 2020 Dec; 29(12):1225-1232. PubMed ID: 33058233
[TBL] [Abstract][Full Text] [Related]
18. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
Glossop JR; Dawes PT; Hassell AB; Mattey DL
J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients.
De Simone C; Farina M; Maiorino A; Fanali C; Perino F; Flamini A; Caldarola G; Sgambato A
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1786-90. PubMed ID: 25726968
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.
Piaserico S; Cazzaniga S; Chimenti S; Giannetti A; Maccarone M; Picardo M; Peserico A; Naldi L;
J Am Acad Dermatol; 2014 Feb; 70(2):257-62.e3. PubMed ID: 24355410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
